Brown researchers awarded $3.8 million grant to study links between alcohol, gut health and HIV

The research, funded by the National Institute on Alcohol Abuse and Alcoholism, aims to uncover how alcohol and HIV disrupt gut bacteria and contribute to chronic health issues like heart disease.

The National Institute on Alcohol Abuse and Alcoholism has awarded a $3.8 million grant to researchers from the Brown University School of Public Health to investigate the intricate links between microbes that live in the gut, heavy alcohol use and HIV.

The five-year grant, in collaboration with researchers at University of Louisville and Vanderbilt University Medical Center, will investigate how alcohol affects gut bacteria in people living with HIV and how these changes contribute to inflammation and health problems such as heart disease. The ultimate goal is to help develop more targeted interventions for alcohol-related gut dysbiosis for people living with HIV.

“Both alcohol and HIV are known to disrupt the gut’s bacterial balance, a condition known as gut dysbiosis, but it’s unclear which specific bacteria drive these harmful effects,” said Mollie Monnig, an assistant professor of behavioral and social sciences with the Center for Alcohol and Addiction Studies.

“The whole idea is we're not going to really understand gut dysbiosis if we don’t look at it at a finer grain level. This funding allows for whole genome sequencing of the gut microbiota in 583 people living with HIV infection who are heavy drinkers, exploring an underexplored but critical area of health for this population of people.”

By identifying what is going haywire, the hope is that there can then be targeted interventions developed to bring the numbers back to healthier levels.

Mollie Monnig Assistant professor of behavioral and social sciences
 
Woman poses for photo

The research team hopes to determine how alcohol use specifically affects bacterial species that produce butyrate, a short chain fatty acid. These specific bacteria play a vital role in immune, cardiovascular and brain health. Reduced levels of these bacteria are linked to increased inflammation, a persistent issue for individuals living with HIV — even those with controlled viral loads.

“Once you deplete those bacteria, they have downstream effects later on if the changes become chronic as it often does in both heavy drinkers and people living with HIV,” Monnig said. “By identifying what is going haywire, the hope is that there can then be targeted interventions developed to bring the numbers back to healthier levels.”

The work builds on two pre-existing cohorts: one from Russia and Tennessee. The participants from the cohorts have already undergone extensive clinical and demographic assessments, including providing behavioral tests and blood and fecal samples.

While the focus is on people living with HIV, the findings could one day have broader applications for heavy drinkers without the condition. Right now, though, the researchers are focused on individuals who experience, what Monnig calls, a “double hit” of drinking heavily and living with HIV.

“It’s about improving not just lifespan for this population but health span, as well, informing future intervention efforts and precision medicine efforts,” Monnig said.